Background: Diabetes mellitus (DM) is a worldwide health problem affecting a population of different ages, which inflicts a large economic load on the worldwide health-care system. This disease is mostly characterized by hyperglycemia which causes deleterious effects on both the macro-and microvasculature. Pharmacological treatment includes many drugs with different mechanisms of action. These drugs aim to control the hyperglycemic state and subsequently may protect the vessels from its deleterious effect. Aim of the Work:The aim of our study is to compare the potential protective effect of three of these antidiabetic drugs; Acarbose, Linagliptin and Quercetin, on the aorta of type 2 diabetes mellitus rat model. Materials and Methods: Forty male albino rats were divided into 5 groups. Two control groups; normal control group (normal group) and diabetic control group (DM group). Diabetes was induced by feeding rats with high-fat diet (HFD) for 2 weeks followed by a single dose Streptozotocin (STZ) injection. Three diabetic groups received different treatments; diabetic group treated with Acarbose (DM+AC group), diabetic group treated with Linagliptin (DM+LN group) and diabetic group treated with Quercetin (DM+QR group). Blood samples were taken for biochemical evaluation and specimens of the aorta were taken for histological and morphometric analysis. Results: Diabetic group showed histological findings recorded in atherosclerotic aorta. The three tested antidiabetic drugs Acarbose, Linagliptin and Quercetin, showed an ameliorative effect on the structure of the aorta but no noticeable differences were recorded. Conclusion:Our study revealed that the changes produced in the structure of the aorta of the diabetic group were ameliorated in the groups received the three drugs with no noticeable differences between them.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.